Allergy & Immunology Doctors in Oakland, CA Accepting Medicare

5 Allergy & Immunology doctors found. Showing 1 - 5

Kathleen Anne Clanon, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1411 E 31st Street, Oakland, CA 94602 Phone: 510-437-4323    Fax: 510-437-5042

Dr. David B. Moyer, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 3801 Howe St, Oakland, CA 94611 Phone: 510-752-6439    Fax: 510-752-6872

Jimmy Ko, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 275 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-1000

Dean G. Kardassakis, MD Allergy & Immunology - Allergy Medicare: Accepting Medicare Assignments Practice Location: 275 W Macarthur, Oakland, CA 94611 Phone: 510-752-1000    Fax: 650-692-5493

Debby A. Lin, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 275 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-1000

News Archive

Gum disease associated with greater risk of high blood pressure

People with gum disease (periodontitis) have a greater likelihood of high blood pressure (hypertension), according to a study published today in Cardiovascular Research, a journal of the European Society of Cardiology.

Dartmouth Atlas: Big differences in how academic med centers train residents

A report from the Dartmouth Atlas Project found significant variations in quality, safety and end-of-life care.

DCR to present data on DaVita Cathaway program at ASN Annual Meeting

DaVita Clinical Research, a provider of clinical research and diagnostic laboratory services, announced today that 56 posters and five oral presentations will be presented by the Company's unsurpassed renal experts at the 43rd American Society of Nephrology (ASN) Annual Meeting and Scientific Exposition from November 16 - 21, 2010, at the Colorado Convention Center located in Denver, Colorado.

Children could be saved from neuroblastoma using antibody therapy

Combination of T cell, antibody to neuroblastoma cells and molecule that spurs T cell growth is designed to treat low initial tumor levels or small cancer cell populations that survive initial treatment, according to St. Jude.

Biomet Biologics initiates enrollment in MarrowStim P.A.D. Kit IDE trial for critical limb ischemia

Biomet, a global leader in the manufacture of orthopedic and biotechnology products, announced today that its subsidiary, Biomet Biologics, has enrolled the first subject into its multicenter, prospective, randomized, double-blind, placebo-controlled clinical trial for critical limb ischemia (CLI).

Read more Medical News

› Verified 1 days ago